Skip to main content
. 2014 Feb 6;3:71. doi: 10.1186/2193-1801-3-71

Table 3.

Clinicopathologic and Recurrence Score results in patients with a treatment change ( n= 24)

Type of treatment change
Pre-testing: HT. Post-testing: CHT. Pre-testing: CHT. Post-testing: HT.
(n = 11) (n = 13)
Age a
 Mean (SD), years 54.2 (3.4) 55.1 (9.5)
 Median (range), years 54 (46-58) 56 (35-72)
Tumor size b
 Mean (SD), mm 15.6 (5.7) 20.4 (7.6)
 Median (range), mm 14 (10-28) 20.5 (10-32)
Nodal status, c n (%)
 Node negative 10 (100) 8 (72.7)
 Node positive 0 (0) 3 (27.3)
Tumor grade, d n (%)
 1 1 (9.1) 0 (0)
 2 8 (72.7) 7 (63.6)
 3 2 (18.2) 4 (36.4)
Type of surgery, e n (%)
 Lumpectomy 10 (90.9) 9 (69.2)
 Mastectomy 1 (9.1) 4 (30.8)
Recurrence Score result f
 Mean (SD) 27.3 (1.7) 21.1 (3.0)
 Median (range) 28 (23-29) 20 (18-28)

CHT chemohormonal therapy; HT hormonal therapy; SD standard deviation.

a P = 0.76 (t-test for comparing means).

b P = 0.11 (t-test for comparing means). Tumor size information was unavailable for 1 patient in the chemohormonal to hormonal therapy group.

c P = 0.21 (Fisher’s exact test). Nodal status information was unavailable for 1 patient in the hormonal therapy to chemohormonal therapy group and 2 patients in the chemohormonal to hormonal therapy group.

d P = 0.64 (Fisher’s exact test). Grade information was unavailable for 2 patients in the chemohormonal to hormonal therapy group.

e P = 0.33 (Fisher’s exact test).

f P = 0.0014 (MWW test).